Maarten Jacquemyn

12PUBLICATIONS
74CO-AUTHORS
Molecular targetsHaematologyHaematological tumoursIndustrial molecular engineering of nucleic acids and proteinsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 24, 2026
Preclinical characterization of a reversible XPO1 inhibitor for cancer therapy.

|Jun 15, 2026
New determinant of influenza hemagglutinin cleavability identified through random mutagenesis for acid-stabilizing mutations.

|Mar 23, 2026
ADA2-deficient cells exhibit increased levels of cell death and metabolic disturbances.

Lisa Ehlers, Marjon Wouters, Bethany Pillay

|Nov 25, 2025
SINE compounds activate exportin 1 degradation through an allosteric mechanism.

Casey E Wing, Ho Yee Joyce Fung, Bert Kwanten

|Nov 23, 2024
Ibetazol, a novel inhibitor of importin β1-mediated nuclear import.

Thomas Vercruysse, Els Vanstreels, Maarten Jacquemyn

|Oct 02, 2024
Intrinsic temperature increase drives lipid metabolism towards ferroptosis evasion and chemotherapy resistance in pancreatic cancer.

Vincent de Laat, Halit Topal, Xander Spotbeen

Pageof 2

Frequent Collaborators

10 joint publications

Dirk Daelemans

2 joint publications

Ho Yee Joyce Fung

2 joint publications

Yuh Min Chook

2 joint publications

Bert Kwanten